This is a Scorecard review, revisiting a past LF0 research call against what actually happened.
Ticker: WGS Rating: Sell Published: 2026-08-09 Checkpoint: 2026-11-09 Entry price: $77.88 Latest price: $62.37 as of 2026-11-06 Stock return since entry: -19.9% Signal return: +19.9% Verdict: Correct so far
This is the 3-month checkpoint for this call. LF0 publishes monthly Scorecard updates through month 6, using the closest available daily close on or before the checkpoint date.
Previous checkpoint: our 2-month review (2026-10-09) was correct (stock return -13.5% since entry). Each monthly review is judged on its own date, so the verdict can change from one month to the next.
Read the original LF0 analysis
What I Said
I rated WGS a Sell because I thought the business quality was better than it used to be, but the operating evidence still had not caught up: gross margin was healthy at 69.4%, while operating margin was still -15.2% and free cash flow margin was -10.5%. I also pointed to the valuation as vulnerable if the company could not turn that revenue growth into self-funding earnings, and I wanted to see free cash flow turn positive and receivables stop outrunning revenue before I would soften the call.
Peer Comparison
| Company | Return Since Entry |
|---|---|
| WGS (this call) | -19.9% |
| FLGT | +24.6% |
| GH | -9.8% |
| NTRA | -2.4% |
| TEM | +38.1% |
| VEEV | +29.4% |
How Other Analysts Rate It
Every Wall Street rating action logged on Yahoo Finance since our Sell on 2026-08-10, one row per action (a firm that updates three times appears three times). LF0 rows are in bold.
| Date | Firm | Rating | Action | Price target |
|---|---|---|---|---|
| 2026-08-10 | LF0 Equity Research | Sell | Original call at $77.88 | |
| 2026-09-09 | LF0 Equity Research | Sell | 1-month update | |
| 2026-10-01 | Guggenheim | Buy | Reiterated | $83.00 (from $74.00) |
| 2026-10-09 | LF0 Equity Research | Sell | 2-month update | |
| 2026-11-09 | LF0 Equity Research | Sell | 3-month update (this report) |
No analyst changed their rating on this stock since our Sell on 2026-08-10; the table shows reiterations and price-target changes only.
1 firm still Buy-rated against our call at their latest action: Guggenheim.
Counting each firm’s latest action in this window: 1 bullish, 0 neutral, 0 bearish out of 1 firms.
Source: Yahoo Finance analyst rating actions. Dates are when Yahoo logged the action. Analyst ratings are third-party opinions, not LF0 views or recommendations.
Why It’s Working (Or Not)
Over this tracking window, following my Sell would have earned 19.9%, which means the bearish call has worked to date. WGS has fallen from my entry price, and that move is consistent with my view that the moat was real but the earnings and cash conversion were not yet there. The peer set has been mixed to higher overall, with several comparables up over the same stretch, so WGS has not simply moved in lockstep with the group. That divergence supports the part of my thesis that the stock was vulnerable if the market stopped rewarding the story before the operating model proved itself.
What Could Still Prove Me Wrong
If WGS can show a sustained margin inflection and free cash flow turns positive, that would directly challenge the core of my bearish view. I would also reconsider if revenue growth reaccelerates into the high teens while receivables stop rising faster than revenue, because that would suggest the reimbursement and collections issues are easing. If the company keeps burning cash at roughly the same pace and the valuation starts to re-rate on hope alone, that would reinforce the original Sell rather than weaken it.
The August 2026 Cohort
Other directional calls published the same month:
| Ticker | Rating | Entry | Latest | Stock Return | Signal Return | Verdict |
|---|---|---|---|---|---|---|
| SDGR | Sell | $17.40 | $29.82 | +71.4% | -71.4% | Incorrect so far |
| NUTX | Buy | $188.41 | $180.56 | -4.2% | -4.2% | Incorrect so far |
| AES | Sell | $14.54 | $14.87 | +2.3% | -2.3% | Incorrect so far |
| GTN | Sell | $4.83 | $4.92 | +1.9% | -1.9% | Incorrect so far |
| LHX | Sell | $260.92 | $259.89 | -0.4% | +0.4% | Correct so far |
| VNOM | Sell | $41.67 | $40.62 | -2.5% | +2.5% | Correct so far |
| PENN | Sell | $18.56 | $17.43 | -6.1% | +6.1% | Correct so far |
| RRGB | Sell | $9.51 | $8.62 | -9.4% | +9.4% | Correct so far |
| BA | Sell | $210.46 | $173.40 | -17.6% | +17.6% | Correct so far |
| SPHR | Sell | $147.34 | $120.02 | -18.5% | +18.5% | Correct so far |
| NNDM | Sell | $1.65 | $1.32 | -20.0% | +20.0% | Correct so far |
| NXE | Sell | $10.40 | $8.25 | -20.7% | +20.7% | Correct so far |
| STXS | Sell | $1.39 | $1.09 | -21.6% | +21.6% | Correct so far |
| OI | Sell | $6.79 | $5.17 | -23.9% | +23.9% | Correct so far |
| OWLT | Sell | $5.81 | $4.17 | -28.2% | +28.2% | Correct so far |
| SRG | Strong Sell | $2.11 | $1.71 | -19.0% | +28.4% | Correct so far |
| LRCX | Sell | $343.48 | $200.44 | -41.6% | +41.6% | Correct so far |
| ADTN | Sell | $7.76 | $4.04 | -47.9% | +47.9% | Correct so far |
Sector Scorecard: Healthcare
How are our Healthcare calls doing overall, and where does WGS sit among them?
| Peer call | Rating | Published | Signal return |
|---|---|---|---|
| CUE | Sell | 2026-09-02 | +30.5% |
| OWLT | Sell | 2026-08-12 | +28.2% |
| STXS | Sell | 2026-08-16 | +21.6% |
| VKTX | Strong Sell | 2026-10-29 | +0.1% |
| CRSP | Strong Sell | 2026-10-26 | -3.2% |
| NUTX | Buy | 2026-08-16 | -4.2% |
| BSX | Buy | 2026-06-14 | -5.1% |
| EVH | Strong Sell | 2026-10-27 | -5.4% |
Across sectors, Technology led our directional book with a +29.0% average signal return and an 88% hit rate, while Industrials also performed strongly at +24.4% with an 87% hit rate. Healthcare lagged the table at +0.5% with a 45% hit rate, and its best call was CUE +30.5% versus a worst call of SDGR -71.4%. Consumer Cyclical posted a 100% hit rate on 4 calls, but samples are thin in Utilities, Financial Services, Basic Materials, Consumer Cyclical, and the thin sectors not ranked were Real Estate (2 calls) and Unclassified (2 calls).
Sector League Table
| Sector | Calls | Hit rate | Avg signal return | Best | Worst |
|---|---|---|---|---|---|
| Technology | 25 | 88% | +29.0% | CIFR +70.0% | NLST -133.6% |
| Financial Services | 4 | 75% | +27.2% | HUT +46.5% | BMNR -5.7% |
| Industrials | 15 | 87% | +24.4% | BW +81.7% | AMPX -23.9% |
| Utilities | 3 | 33% | +19.7% | FLNC +63.5% | AES -2.3% |
| Basic Materials | 4 | 75% | +18.3% | LAR +36.6% | UAN -1.0% |
| Communication Services | 5 | 60% | +14.4% | LUMN +42.4% | GTN -1.9% |
| Energy | 6 | 83% | +11.2% | BORR +27.0% | SM -25.9% |
| Consumer Cyclical | 4 | 100% | +9.9% | OI +23.9% | FLUT +0.2% |
| Healthcare | 11 | 45% | +0.5% | CUE +30.5% | SDGR -71.4% |
| Real Estate* | 2 | 50% | +9.4% | SRG +28.4% | SKYH -9.7% |
| Unclassified* | 2 | 50% | -8.9% | NXE +20.7% | FISV -38.6% |
\* Fewer than 3 calls: not ranked.
Sector by Publish Month
| Sector | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 | Oct 2026 | Nov 2026 |
|---|---|---|---|---|---|---|
| Technology | +48.7% (2) | +10.7% (7) | +36.5% (3) | +38.5% (6) | +30.3% (7) | — |
| Industrials | +81.7% (1) | +43.8% (5) | +9.0% (2) | +10.7% (3) | +13.2% (3) | -23.9% (1) |
| Healthcare | -5.1% (1) | — | -1.2% (5) | +30.5% (1) | -2.9% (3) | -5.6% (1) |
| Energy | — | +19.1% (1) | +2.5% (1) | +27.0% (1) | +6.2% (3) | — |
| Communication Services | — | +13.2% (1) | +8.3% (2) | -0.4% (1) | +42.4% (1) | — |
| Consumer Cyclical | — | — | +13.1% (3) | — | — | +0.2% (1) |
| Basic Materials | — | -1.0% (1) | — | +36.6% (1) | +18.7% (2) | — |
| Financial Services | — | +28.8% (3) | — | — | +22.4% (1) | — |
| Utilities | — | +63.5% (1) | -2.3% (1) | — | -2.0% (1) | — |
| Unclassified | — | — | +20.7% (1) | — | -38.6% (1) | — |
| Real Estate | -9.7% (1) | — | +28.4% (1) | — | — | — |
Each cell: average signal return to date of the calls published that month (calls in brackets). Signal return is direction-adjusted, so a positive number means our call is right.
Live LF0 scorecard: The Scorecard | Research Performance dashboard
Past performance does not guarantee future results. Nothing here is investment advice or a recommendation to buy or sell securities. Returns use LF0’s daily-close scorecard methodology.
Leave a Comment